Application of Multimodal Ultrasonography in Parotid Gland Tumors

Differential Diagnosis of Benign and Malignant Parotid Gland Tumors by Multimodal Ultrasound and the Establishment of Scoring System

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100044188

Enrollment

Unknown

Registered

2021-03-12

Start date

2021-04-01

Completion date

Unknown

Last updated

2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parotid Gland Tumors

Interventions

Gold Standard:Pathological diagnosis

Index test:multimodal&#32

ultrasound

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: The inpatients and outpatients with parotid tumor who come to our department for contrast-enhanced ultrasound examination, over 18 years old, male or female.

Exclusion criteria

Exclusion criteria: Patients with history of allergy to contrast media; patients with severe cardiopulmonary disease, adult respiratory distress syndrome, recent symptoms of acute coronary syndrome or clinical unstable ischemic heart disease); elderly patients (> 80 years old); pregnant and lactating women; other patients who are not suitable for contrast-enhanced ultrasonography.

Design outcomes

Primary

Measure	Time frame
Two-dimensional ultrasonic parameters;Color Doppler Flow Imaging parameters;Acoustic Radiation Force Impulse parameters;Contrast-Enhanced Ultrasound parameters;Facial Paralysis;	—

Countries

China

Contacts

Public ContactXiong Ping

The Ninth People's Hospital, Shanghai Jiaotong University School of Medicine

xiong_ping_xp@163.com+86 21-53315236

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026